GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inventiva SA (NAS:IVA) » Definitions » Price-to-Tangible-Book

Inventiva (Inventiva) Price-to-Tangible-Book : (As of Jun. 04, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Inventiva Price-to-Tangible-Book?

As of today (2024-06-04), Inventiva's share price is $3.55. Inventiva's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.68. Hence, Inventiva's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Inventiva's Price-to-Tangible-Book or its related term are showing as below:

During the past 11 years, Inventiva's highest Price to Tangible Book Ratio was 5.45. The lowest was 1.35. And the median was 3.46.

IVA's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.81
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Inventiva's share price is $3.55. Inventiva's Book Value per Sharefor the quarter that ended in Dec. 2023 was $-0.67. Hence, Inventiva's P/B Ratio of today is .


Inventiva Price-to-Tangible-Book Historical Data

The historical data trend for Inventiva's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventiva Price-to-Tangible-Book Chart

Inventiva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.18 5.61 3.95 -

Inventiva Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.61 3.27 3.95 - -

Competitive Comparison of Inventiva's Price-to-Tangible-Book

For the Biotechnology subindustry, Inventiva's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventiva's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inventiva's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Inventiva's Price-to-Tangible-Book falls into.



Inventiva Price-to-Tangible-Book Calculation

Inventiva's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=3.55/-0.682
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Inventiva Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Inventiva's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Inventiva (Inventiva) Business Description

Traded in Other Exchanges
Address
50 rue de Dijon, Daix, FRA, 21121
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Most of the group's revenue is derived from its research partnerships with AbbVie and BI.